Skip to content

Study · Not a test of the peptide alone · 2023

1 result

Palliative care and Chinese medicine in a centenarian with primary hepatocellular carcinoma and 27-month follow-up: A case report.

Hu Y, Lan XH, Cao YJ, Duan JQ, Ren QT, Jin Y, Yin QX, Deng RB

Heliyon3 Jul 2023Cited by 1 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin alpha-1.

  1. 01HumanNot a test of Thymosin alpha-1 aloneCase report or seriesSafety outcome

    In a 104-year-old man with primary liver cancer, a regimen of Chinese herbal medicine, nutritional support and intermittent thymalfasin injection was tolerated, with no tumor complications over 27 months.

    In plain wordsIn one 104-year-old man with liver cancer, a mix of herbal medicine, nutrition and thymalfasin was tolerated for 27 months without tumor complications.

    Outcome
    No significant changeTolerance and tumor complications over 27 months
    Study

    n = 1

    Outcome group
    Adverse events · Cancer

    Source sentences

    Summary
    During the 27-month follow-up, the patient has showed good compliance and tolerance without any complications of the tumor.
    2 context sentences
    Summary · context
    He has been mainly received Chinese herbal medicine (CHM), nutritional support and thymalfasin injection intermittently, etc.
    Summary · context
    We report a 104-year-old man with asymptomatic primary liver cancer (PLC) whose family decided to receive conservative and palliative care.

    In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:19 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.